NCT00144378View on ClinicalTrials.gov

Irinotecan Versus Only Best Supportive Care for Gastric Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

October 31, 2002

Conditions
Stomach NeoplasmNeoplasm Metastasis
Interventions
DRUG

Irinotecan

Trial Locations (1)

Unknown

Charité,Universitätsmedizin Berlin, Campus Virchow Klinikum, Dep. orf Hematology and Oncology,, Berlin

All Listed Sponsors
lead

Charite University, Berlin, Germany

OTHER

NCT00144378 - Irinotecan Versus Only Best Supportive Care for Gastric Cancer | Biotech Hunter | Biotech Hunter